<- Go Home
Hamilton Thorne Ltd.
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts. As of November 29, 2024, Hamilton Thorne Ltd. was taken private.
Market Cap
CAD 245.4M
Volume
108.8K
Cash and Equivalents
CAD 6.9M
EBITDA
CAD 4.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CAD 38.9M
Profit Margin
50.92%
52 Week High
CAD 1.60
52 Week Low
CAD 0.85
Dividend
N/A
Price / Book Value
3.76
Price / Earnings
-109.89
Price / Tangible Book Value
19.00
Enterprise Value
CAD 263.8M
Enterprise Value / EBITDA
50.44
Operating Income
CAD 926.7K
Return on Equity
3.43%
Return on Assets
0.58
Cash and Short Term Investments
CAD 6.9M
Debt
CAD 25.2M
Equity
CAD 65.3M
Revenue
CAD 76.3M
Unlevered FCF
CAD 2.9M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium